Biblio

Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is O  [Clear All Filters]
2023
Heo Y-A. Omidubicel: First Approval. Mol Diagn Ther. 2023.
Huang X, Liang F, Huang B, Luo H, Shi J, Wang L, Peng J, Chen Y. On-chip real-time impedance monitoring of hiPSC-derived and artificial basement membrane-supported endothelium. Biosens Bioelectron. 2023;235:115324.
Pichavaram P, Jablonowski CM, Fang J, Fleming AM, Gil HJin, Boghossian AS, Rees MG, Ronan MM, Roth JA, Morton CL, et al. Oncogenic cells of renal embryonic lineage sensitive to the small molecule inhibitor QC6352 display depletion of KDM4 levels and disruption of ribosome biogenesis. Mol Cancer Ther. 2023.
Ou Z-Y, Wang K, Shen W-W, Deng G, Xu Y-Y, Wang L-F, Zai Z-Y, Ling Y-A, Zhang T, Peng X-Q, et al. Oncogenic FLT3 internal tandem duplication activates E2F1 to regulate purine metabolism in acute myeloid leukaemia. Biochem Pharmacol. 2023:115458.
Fischer AD, Veronese-Paniagua DA, Swaminathan S, Kashima H, Rubin DC, Madison BB. The oncogenic function of PLAGL2 is mediated via ASCL2 and IGF2 and a Wnt-independent mechanism in colorectal cancer. Am J Physiol Gastrointest Liver Physiol. 2023.
Desai R, Huang L, Gonzalez RS, Muthuswamy SK. Oncogenic GNAS uses PKA-dependent and independent mechanisms to induce cell proliferation in human pancreatic ductal and acinar organoids. Mol Cancer Res. 2023.
Capik O, Gundogdu B, Tatar A, Sahin A, Chen F, Creighton CJ, Karatas OFaruk. Oncogenic miR-1825 promotes head and neck carcinogenesis via targeting FREM1. J Cell Biochem. 2023.
Anon. Oncogenic Mutations Control Stem Cell Polarization in Colorectal Cancer. Cancer Discov. 2023:OF1.
Insco ML, Abraham BJ, Dubbury SJ, Kaltheuner IH, Dust S, Wu C, Chen KY, Liu D, Bellaousov S, Cox AM, et al. Oncogenic mutations impede nuclear RNA surveillance. Science. 2023;380(6642):eabn7625.
Qin X, Rodriguez FCardoso, Sufi J, Vlckova P, Claus J, Tape CJ. An oncogenic phenoscape of colonic stem cell polarization. Cell. 2023;186(25):5554-5568.e18.
An N, Khan S, Imgruet MK, Jueng L, Gurbuxani S, McNerney ME. Oncogenic RAS promotes leukemic transformation of CUX1-deficient cells. Oncogene. 2023.
Sunaga N, Kaira K, Shimizu K, Tanaka I, Miura Y, Nakazawa S, Ohtaki Y, Kawabata-Iwakawa R, Sato M, Girard L, et al. The oncogenic role of LGR6 overexpression induced by aberrant Wnt/β-catenin signaling in lung cancer. Thorac Cancer. 2023.
Luo J, Zou H, Guo Y, Tong T, Chen Y, Xiao Y, Pan Y, Li P. The oncogenic roles and clinical implications of YAP/TAZ in breast cancer. Br J Cancer. 2023.
Sell T, Klotz C, Fischer MM, Astaburuaga-García R, Krug S, Drost J, Clevers H, Sers C, Morkel M, Blüthgen N. Oncogenic signaling is coupled to colorectal cancer cell differentiation state. J Cell Biol. 2023;222(6).
Duffau H. Oncological and functional neurosurgery: Perspectives for the decade regarding diffuse gliomas. Rev Neurol (Paris). 2023.
Kardani K, Gil JSanchez, Rabkin SD. Oncolytic herpes simplex viruses for the treatment of glioma and targeting glioblastoma stem-like cells. Front Cell Infect Microbiol. 2023;13:1206111.
Xie L, Yin Y, Jayakar S, Kawaguchi R, Wang Q, Peterson S, Shi C, Turnes BLenfers, Zhang Z, Oses-Prieto J, et al. The oncomodulin receptor ArmC10 enables axon regeneration in mice after nerve injury and neurite outgrowth in human iPSC-derived sensory neurons. Sci Transl Med. 2023;15(708):eadg6241.
Yarandi N, Shirali AC. Onconephrology: Core Curriculum 2023. Am J Kidney Dis. 2023.
Selamet U, Ahdoot RS, Salasnek R, Abdelnour L, Hanna RM. Onconephrology: mitigation of renal injury in chemotherapy administration. Curr Opin Nephrol Hypertens. 2023.
Polak KL, Tamagno I, Parameswaran N, Smigiel J, E Chan R, Yuan X, Rios B, Jackson MW. Oncostatin-M and OSM-Receptor feed-forward activation of MAPK induces separable stem-like and mesenchymal programs. Mol Cancer Res. 2023.
Sibia US, Mylander C, Martin T, Rosman M, Sanders TJ, Lee Y, Tafra L, Jackson RS. OncotypeDX Testing Does Not Benefit Patients with Estrogen and Progesterone Receptor Positive Grade 1 Breast Cancers: A TAILORx Validated Study. Hematol Oncol Stem Cell Ther. 2023;16(4):412-419.
Hou L-Q, Liu J-R, Gu J-L, Chen M-L, Kuang L-F, Huang B-H, Zou W-Y, Li J. On-demand plerixafor added to high-dose cyclophosphamide and pegylated recombinant human granulocyte colony-stimulating factor in the mobilization of patients with multiple myeloma: a treatment with high effectiveness, convenient, and affordable cost. Front Oncol. 2023;13:1306367.
Häuser F, Mittler J, Hantal MSimge, Greulich L, Hermanns M, Shrestha A, Kriege O, Falter T, Immel UD, Herold S, et al. One fits all: a highly sensitive combined ddPCR/pyrosequencing system for the quantification of microchimerism after hematopoietic and solid organ transplantation. Clin Chem Lab Med. 2023.
Daniels A, Fletcher S, Kerr HEM, Kratzel A, Pinto RMaria, Kriplani N, Craig N, C Hastie J, Davies P, Digard P, et al. One for all-human kidney Caki-1 cells are highly susceptible to infection with corona- and other respiratory viruses. J Virol. 2023:e0055523.
Ventre E, Herbach U, Espinasse T, Benoit G, Gandrillon O. One model fits all: Combining inference and simulation of gene regulatory networks. PLoS Comput Biol. 2023;19(3):e1010962.

Pages